Benzinga
Benzinga
Benzinga
miércoles, septiembre 30

Benitec Biopharma Inc

BNTCNASDAQ
Trade with Public
Trade with Public
$10.00
0.252.56%
Últ. Act.: Sep 30, 12:36 PM
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararInforme de acciones

Benitec Biopharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Benitec Biopharma (BNTC).

Price Target Range — 11 Quarters

Analyst Consensus — 11 Analysts

3S.Buy
8Buy
Consensus RatingOutperform# Analysts11Avg. Consensus PT$23Upside to Avg. PT+130.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →
DateFirmAnalystActionRating ChangePrice Target
Sep 15, 2026WedbushYun ZhongPT RaiseOutperform$16→$17
Jul 28, 2026WedbushYun ZhongInitiateOutperform$16
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wedbush Maintains Outperform on Benitec Biopharma, Raises Price Target to $17

Wedbush analyst Yun Zhong maintains Benitec Biopharma (NASDAQ:BNTC) with a Outperform and raises the price target from $16 to $17.
Benzinga Newsdesk

This Crowdstrike Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed outlook on top names. See all rating changes on analyst ratings page. Analysts have positive views on FTH stock.
Avi Kapoor

PRO
Wedbush Initiates Coverage On Benitec Biopharma with Outperform Rating, Announces Price Target of $16

Wedbush analyst Yun Zhong initiates coverage on Benitec Biopharma (NASDAQ:BNTC) with a Outperform rating and announces Price Target of $16.
Benzinga Newsdesk

PRO
Evercore ISI Group Initiates Coverage On Benitec Biopharma with Outperform Rating, Announces Price Target of $25

Evercore ISI Group analyst Cory Kasimov initiates coverage on Benitec Biopharma (NASDAQ:BNTC) with a Outperform rating and announces Price Target of $25.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Benitec Biopharma, Maintains $32 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Benitec Biopharma (NASDAQ:BNTC) with a Buy and maintains $32 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Benitec Biopharma, Lowers Price Target to $32

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Benitec Biopharma (NASDAQ:BNTC) with a Buy and lowers the price target from $35 to $32.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved